Modulation of alternative splicing induced by paclitaxel in human lung cancer

TRA2A Promoted Paclitaxel Resistance and Tumor Progression in Triple-Negative Breast Cancers via Regulating Alternative Splicing

(2017) Tieju Liu et al.   MOLECULAR CANCER THERAPEUTICS

Gene isoforms as expression-based biomarkers predictive of drug response in vitro

(2017) Zhaleh Safikhani et al.   Nature Communications

Inhibition of Spleen Tyrosine Kinase Potentiates Paclitaxel-Induced Cytotoxicity in Ovarian Cancer Cells by Stabilizing Microtubules

(2015) Yu Yu et al.   CANCER CELL

MYC Is a Major Determinant of Mitotic Cell Fate

(2015) Caroline Topham et al.   CANCER CELL

Mutations of p53 and KRAS activate NF-κB to promote chemoresistance and tumorigenesis via dysregulation of cell cycle and suppression of apoptosis in lung cancer cells

(2015) Lina Yang et al.   CANCER LETTERS

ECT2 regulates the Rho/ERK signalling axis to promote early recurrence in human hepatocellular carcinoma

(2015) Jianxiang Chen et al.   JOURNAL OF HEPATOLOGY

Randomized, Phase III Trial of First-Line Figitumumab in Combination With Paclitaxel and Carboplatin Versus Paclitaxel and Carboplatin Alone in Patients With Advanced Non–Small-Cell Lung Cancer

(2014) Corey J. Langer et al.   JOURNAL OF CLINICAL ONCOLOGY

Cytotoxicity of Paclitaxel in Breast Cancer Is due to Chromosome Missegregation on Multipolar Spindles

(2014) L. M. Zasadil et al.   Science Translational Medicine

Identification of a Novel Role of ZMIZ2 Protein in Regulating the Activity of the Wnt/β-Catenin Signaling Pathway

(2013) Suk Hyung Lee et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Hallmarks of alternative splicing in cancer

(2013) S Oltean et al.   ONCOGENE

Changes in Ect2 Localization Couple Actomyosin-Dependent Cell Shape Changes to Mitotic Progression

(2012) Helen K. Matthews et al.   DEVELOPMENTAL CELL

FMNL3 FH2–actin structure gives insight into formin-mediated actin nucleation and elongation

(2012) Morgan E Thompson et al.   NATURE STRUCTURAL & MOLECULAR BIOLOGY

Abnormal Expression of the Pre-mRNA Splicing Regulators SRSF1, SRSF2, SRPK1 and SRPK2 in Non Small Cell Lung Carcinoma

(2012) Stephanie Gout et al.   PLoS One

SRSF1 Regulates the Alternative Splicing of Caspase 9 Via A Novel Intronic Splicing Enhancer Affecting the Chemotherapeutic Sensitivity of Non-Small Cell Lung Cancer Cells

(2011) J. C. Shultz et al.   MOLECULAR CANCER RESEARCH

Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged

(2010) C. J. David et al.   GENES & DEVELOPMENT

Stabilization of anaphase midzone microtubules is regulated by Rho during cytokinesis in human fibrosarcoma cells

(2009) Masamitsu Kanada et al.   EXPERIMENTAL CELL RESEARCH